Dulai PS, Wong ECL, Reinisch W, Colombel JF, et al. Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab. Inflamm Bowel Dis 2021 Dec 30. pii: 6490022. doi: 10.1093.
PMID: 34967397